Skip to main content
. 2020 Sep 28;15(9):e0239675. doi: 10.1371/journal.pone.0239675

Table 3. Demographic and clinical characteristics of patients with confirmed Fabry Disease (FD).

Age of diagnosis of FD (years) Age of first presentation (years) Initial presentation ECG data ERT Baseline septal wall thickness (mm) Septal wall thickness at 6 months after ERT commencement (mm)
74 71 Incidental murmur; aortic regurgitation RBBB No 19 19
59 54 Chest pain on exertion LVH Yes 19 18
59 59 Found LVH on echo during evaluation for AF AF, nonspecific intraventricular conduction delay; inferior infarct Yes 24 18.5
62 61 Atypical chest pain and recurrent syncope AF, LVH; 2:1 AV block (requiring pacemaker) No 13 17
61 42 Hypertension and LVH on echo LVH No 17 23

FD indicates Fabry Disease; ECG, electrocardiogram; ERT, enzyme replacement therapy; RBBB, right bundle branch block; LVH, left ventricular hypertrophy; AF, atrial fibrillation; AV, atrioventricular.